|
⚲
|
| Keyboard |
| Melnick David A
✚
|
|
|---|---|
| CIK # | 0001726485 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001726485] | |
| 4 | [0001726485] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Melnick David A | |
| Spero Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Spero Therapeutics Inc SPRO
Stock Option (Right to Buy) · derivative
|
2022-02-01 | Grant | 53,190 | $0.00 | |
|
Spero Therapeutics Inc SPRO
Common Stock
|
2022-02-01 | Grant | 38,014 | $0.00 | |
|
Spero Therapeutics Inc SPRO
Common Stock
|
2021-08-26 | Grant | 24,067 | $0.00 | |
|
Spero Therapeutics Inc SPRO
Stock Option (Right to Buy) · derivative
|
2021-02-01 | Grant | 57,432 | $0.00 | |
|
Spero Therapeutics Inc SPRO
Stock Option (Right to Buy) · derivative
|
2020-02-03 | Grant | 55,000 | $0.00 | |
|
Spero Therapeutics Inc SPRO
Stock Option (Right to Buy) · derivative
|
2019-01-02 | Grant | 65,000 | $0.00 | |
|
Spero Therapeutics Inc SPRO
Stock Option (Right to Buy) · derivative
|
2018-01-04 | Grant | 135,000 | $0.00 |